Google DeepMind has announced the release of AlphaFold 3, a new AI model that predicts the structure and interactions of proteins, DNA, RNA, and small molecules with unprecedented accuracy. The update builds on the success of earlier AlphaFold versions and is positioned to accelerate drug discovery efforts. According to Nature, the model’s improved precision could streamline the early stages of drug development, potentially reducing time and cost. The announcement underscores the expanding influence of artificial intelligence in complex biological research and highlights DeepMind’s continued investment in advancing computational biology tools.
DeepMind Releases AlphaFold 3 for Drug Discovery
Google DeepMind has announced the release of AlphaFold 3, a new AI model that predicts the structure and interactions of proteins, DNA, RNA, and small molecules with unprecedented accuracy. The update builds on the success of earlier AlphaFold versions and is positioned to accelerate drug discovery efforts. The announcement was reported by Nature.
Why it matters
The enhanced predictive power of AlphaFold 3 could streamline the early stages of drug development, reducing time and cost. It also demonstrates the growing role of AI in complex biological research.
Topic dossiers Google DeepMind & Gemini